Journal Article
Prescription Opioid Use in General and Pediatric Emergency Departments
October 16, 2019
Featured Experts: Michael Menchine, MD, MPH
Research
All Research Featured Research
News
Young People Treated in Pediatric Emergency Departments Less Likely to Receive Opioids Compared to Similar Patients Treated in General EDs
October 16, 2019
Featured Experts: Michael Menchine, MD, MPH
Perspective
CBO Estimate on Pelosi Drug Bill Misses its Long-Term Impact on Health
October 16, 2019
Featured Experts: Dana Goldman, PhD
Issue Brief
Future Health Dividends for California: Valuing Medical Innovations
October 15, 2019
Featured Experts: Bryan Tysinger, PhD, Karen Mulligan, PhD, Dana Goldman, PhD
Evidence Base
A Value-Based System Where Healthcare Providers are Accountable for Outcomes Will Benefit Patients
October 14, 2019
Perspective
Accounting for Hope: Using ‘Mean Survival Gain’ to Price New Cancer Drugs
October 14, 2019
Featured Experts: Alice Chen, PhD, Dana Goldman, PhD
Evidence Base
Innovations in Probability-Based Internet Panel Data: Exploring the Understanding America Study
October 8, 2019
News
Newly Approved Cancer Drugs Are Pricey, But Also Show Improved Longer-Term Survival Gains
October 7, 2019
Featured Experts: Alice Chen, PhD, Dana Goldman, PhD
Journal Article
Expanding the Role of the Patient-Centered Outcomes Research Institute: Reauthorization and Facilitating Value Assessments
October 5, 2019
Featured Experts: William Padula, PhD
Journal Article
Trends in the Use of Skilled Nursing Facility and Home Health Care Under the Hospital Readmissions Reduction Program: An Interrupted Time-series Analysis
October 1, 2019
Featured Experts: Neeraj Sood, PhD
Evidence Base
Who Would Have Believed it? Markets Can Reduce the ‘True’ Price of Cancer Drugs
September 28, 2019
Featured Experts: Dana Goldman, PhD
Perspective
California Saw Reduction in Out-of-Network Care from Affected Specialties after 2017 Surprise Billing Law
September 26, 2019
Featured Experts: Erin L. Duffy, PhD, MPH, Bich Ly, Erin Trish, PhD
Journal Article
Analysis of State-Level Drug Pricing Transparency Laws in the United States
September 25, 2019
Featured Experts: Neeraj Sood, PhD
News
Most State Laws Aimed at Improving Drug Pricing Transparency Won’t Help, According to New Study
September 25, 2019
Featured Experts: Neeraj Sood, PhD
White Paper
State Drug Pricing Transparency Laws: Numerous Efforts, Most Fall Short
September 25, 2019
Featured Experts: Neeraj Sood, PhD
Data Visualization
Data Visualization: State Drug Transparency Laws
September 25, 2019
Featured Experts: Neeraj Sood, PhD
Journal Article
Trends in the Price per Median and Mean Life-Year Gained Among Newly Approved Cancer Therapies 1995 to 2017
September 23, 2019
Featured Experts: Alice Chen, PhD, Dana Goldman, PhD
